Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · ABEONA THERAPEUTICS INC. (ABEO)

Abeona Therapeutics director Michael Amoroso resigns from board, citing personal reasons

Neutral Impact 2 of 5 leadership Written later

Abeona Therapeutics director Michael Amoroso resigned from the company's Board of Directors effective immediately on June 11, 2026, and also left the Nominating and Corporate Governance Committee. The filing says the resignation was not due to any disagreement with the company over operations, policies or practices, and cites personal reasons only.

Key points

  • Michael Amoroso resigned from the Board of Directors effective immediately, dated June 11, 2026
  • He also resigned from the Nominating and Corporate Governance Committee
  • The filing states no disagreement with the company on operations, policies or practices; reason given is personal

The filing

CompanyABEONA THERAPEUTICS INC. (ABEO)
Form8-K, current report
Filed with the SECJun 12, 2026, 7:30 AM ET
Accession number0001493152-26-028369

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 12, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.